deCODE genetics, Inc. (Nasdaq:DCGN) today announced that
it will report its first quarter 2007 financial results in
a press release to be issued on Monday, April 30, after the
close of the market in New York. The company will host a
live webcast of its conference call to discuss these results
and recent operating highlights on Tuesday, May 1, at 8am
Eastern Time/12 noon GMT/1 pm British Summer Time.
The webcast can be accessed through the Investors page of
deCODE's website, www.decode.com, or through www.earnings.com.
Please log in to the webcast 15 minutes prior to the scheduled
start of the call. The call will be archived for at least
a week on each site. For those unable to listen to the webcast
because of company firewall or other issues, a digitized
audio replay will also be available by telephone from approximately
11:30am EDT on Tuesday, May 1 and for one week thereafter.
The dial-in replay numbers are: 1 (800) 475-6701 in the U.S.,
and +1 (320) 365-3844 for those calling from outside the
U.S. The access code is 871908.
About deCODE
deCODE
is a
biopharmaceutical
company applying its discoveries in human genetics to the
development of drugs and diagnostics
for common
diseases.
deCODE is a global leader in gene discovery — our population
approach and resources have enabled us
to isolate
key genes
contributing to major public health challenges from cardiovascular
disease to cancer, genes
that
are providing
us with drug targets rooted in the basic biology of disease.
deCODE is also leveraging its expertise
in human
genetics
and integrated drug discovery and development capabilities
to offer
innovative products and services in DNA-based
diagnostics,
bioinformatics, genotyping, structural biology, drug discovery
and clinical development. deCODE
is delivering
on the
promise of the new genetics.SM Visit us on the web at www.decode.com.
Any statements contained in this presentation that relate
to future plans, events or performance are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are subject
to a number of risks and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, among others,
those relating to technology and product development, integration
of acquired businesses, market acceptance, government regulation
and regulatory approval processes, intellectual property rights
and litigation, dependence on collaborative relationships,
ability to obtain financing, competitive products, industry
trends and other risks identified in deCODE’s filings with
the Securities and Exchange Commission. deCODE undertakes
no obligation to update or alter these forward-looking statements
as a result of new information, future events or otherwise.
